These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 8612526

  • 21. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Biochem Pharmacol; 1998 May 01; 55(9):1427-33. PubMed ID: 10076535
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC, Hanrahan S, Totty N, Gamble SC, Waxman J, Cato AC, Hurst HC, Bevan CL.
    Clin Cancer Res; 2004 Nov 01; 10(21):7392-401. PubMed ID: 15534116
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
    Hartig PC, Bobseine KL, Britt BH, Cardon MC, Lambright CR, Wilson VS, Gray LE.
    Toxicol Sci; 2002 Mar 01; 66(1):82-90. PubMed ID: 11861975
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H.
    Cancer Detect Prev; 1996 Mar 01; 20(1):68-75. PubMed ID: 8907206
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 01; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
    Yen PM, Liu Y, Palvimo JJ, Trifiro M, Whang J, Pinsky L, Jänne OA, Chin WW.
    Mol Endocrinol; 1997 Feb 01; 11(2):162-71. PubMed ID: 9013763
    [Abstract] [Full Text] [Related]

  • 35. Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs.
    Holterhus PM, Piefke S, Hiort O.
    J Steroid Biochem Mol Biol; 2002 Nov 01; 82(4-5):269-75. PubMed ID: 12589933
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei.
    Karvonen U, Jänne OA, Palvimo JJ.
    FEBS Lett; 2002 Jul 17; 523(1-3):43-7. PubMed ID: 12123801
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.
    Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Jänne OA.
    Endocrinology; 1994 Oct 17; 135(4):1359-66. PubMed ID: 7925097
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.